Nautilus Biotechnology, Inc. (NAUT) Balance Sheet
NAUT balance sheet, 2025
December 31, 2025 · U.S. dollars$191.1M assets = $34.1M liabilities + $157.0M equity
Both columns are drawn to the same scale: what NAUT owns equals what it owes plus shareholders’ equity. Hover a block for its value.
NAUT financial health
Descriptive bands, not a rating. Fiscal 2025.
NAUT balance sheet trends, 2018–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $145.8M2018 | $191.1M2025 | +3.9%/yr | |
| Total liabilities | $140.8M2018 | $34.1M2025 | −18.3%/yr | |
| Shareholders’ equity | $5.0M2018 | $157.0M2025 | +63.6%/yr | |
| Cash & short-term investments | $144.49B2018 | $103.4M2025 | −64.5%/yr | |
| Total debt | $5.0M2018 | $30.0M2025 | +29.2%/yr | |
| Net cash (debt) | $144.48B2018 | $73.4M2025 | −$144.4B | |
| Working capital | $1.3M2018 | $98.0M2025 | +$96.7M | |
| Book value per share | −$0.902020 | $1.242025 | — | |
| Debt / equity | 1.002018 | 0.192025 | −0.81 | |
| Shares outstanding | 33.1M2020 | 126.3M2025 | +30.7%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
NAUT assets
NAUT liabilities and equity
NAUT debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
NAUT balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & short-term investments | $103.4M | $129.9M | $173.4M | $184.5M | $345.7M | $76.7M | $16.7M | $144.49B |
| Cash & equivalents | $12.4M | $27.6M | $19.4M | $114.5M | $185.6M | $36.6M | $595,000 | $1.2M |
| Short-term investments | $91.0M | $102.2M | $154.0M | $69.9M | $160.1M | $40.1M | $16.1M | $144.49B |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $2.6M | $2.9M | $3.4M | $2.7M | $3.5M | $917,000 | $305,000 | $0 |
| Total current assets | $106.0M | $132.8M | $176.8M | $187.2M | $349.2M | $77.7M | $17.0M | $1.3M |
| Property, plant & equipment (net) | $31.2M | $32.3M | $36.9M | $32.6M | $31.9M | $6.2M | $1.1M | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $52.7M | $76.4M | $90.6M | $129.2M | $16.4M | $0 | $0 | $0 |
| Other non-current assets | $1.2M | $1.2M | $1.2M | $1.1M | $997,000 | $1.1M | $459,000 | $144.5M |
| Total assets | $191.1M | $242.7M | $305.6M | $350.1M | $398.4M | $85.0M | $18.5M | $145.8M |
| Liabilities | ||||||||
| Accounts payable | $943,000 | $987,000 | $1.6M | $1.3M | $1.7M | $470,000 | $289,000 | — |
| Short-term debt | $3.8M | $4.1M | $3.5M | $2.0M | $970,000 | $1.5M | — | — |
| Deferred revenue | — | — | −$948,000 | — | $2.7M | $936,000 | — | — |
| Total current liabilities | $8.0M | $7.6M | $9.1M | $6.8M | $5.8M | $3.0M | $490,000 | $5,000 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $30.0M | $30.5M | $34.6M | $30.3M | $30.0M | $4.8M | — | — |
| Other long-term liabilities | $26.2M | $26.4M | $31.1M | $28.3M | $29.1M | $111.7M | $275.0M | $5.0M |
| Total liabilities | $34.1M | $34.0M | $40.2M | $35.1M | $34.9M | $114.7M | $490,000 | $140.8M |
| Shareholders' equity | ||||||||
| Common stock & paid-in capital | $13,000 | $13,000 | $13,000 | $12,000 | $12,000 | $1,000 | $1,000 | $76 |
| Retained earnings (deficit) | −$332.0M | −$273.0M | −$202.2M | −$138.6M | −$80.6M | −$30.3M | −$14.7M | $626,600 |
| Accumulated other comprehensive income | $243,000 | $57,000 | −$255,000 | −$1.9M | −$184,000 | $3,000 | $7,000 | — |
| Total shareholders' equity | $157.0M | $208.7M | $265.4M | $314.9M | $363.6M | −$29.7M | $18.1M | $5.0M |
| Key figures | ||||||||
| Total debt | $30.0M | $30.5M | $34.6M | $30.3M | $30.0M | $4.8M | $275.0M | $5.0M |
| Net cash (debt) | $73.4M | $99.4M | $138.8M | $154.1M | $315.7M | $72.0M | −$258.3M | $144.48B |
| Working capital | $98.0M | $125.2M | $167.7M | $180.4M | $343.4M | $74.6M | $16.5M | $1.3M |
| Tangible book value | $157.0M | $208.7M | $265.4M | $314.9M | $363.6M | −$29.7M | $18.1M | $5.0M |
| Book value per share | $1.24 | $1.66 | $2.12 | $2.53 | $4.30 | −$0.90 | — | — |
| Shares outstanding | 126.3M | 125.4M | 124.9M | 124.6M | 84.5M | 33.1M | — | — |
| Current ratio | 13.33 | 17.40 | 19.39 | 27.57 | 60.09 | 25.73 | 34.62 | 266.45 |
| Quick ratio | 13.00 | 17.02 | 19.01 | 27.16 | 59.49 | 25.43 | 34.00 | 28,897,896.46 |
| Debt / equity | 0.19 | 0.15 | 0.13 | 0.10 | 0.08 | — | 15.23 | 1.00 |
| Equity / assets | 82.1% | 86.0% | 86.8% | 90.0% | 91.2% | −35.0% | 97.4% | 3.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $84.0M | $95.9M | $103.4M | $131.4M | $147.9M | $138.8M | $129.9M | $140.6M | $167.4M | $181.4M | $173.4M | $183.3M |
| Cash & equivalents | $13.2M | $14.6M | $12.4M | $23.9M | $34.5M | $33.2M | $27.6M | $4.4M | $24.9M | $25.7M | $19.4M | $74.1M |
| Short-term investments | $70.9M | $81.2M | $91.0M | $107.6M | $113.4M | $105.6M | $102.2M | $136.2M | $142.6M | $155.6M | $154.0M | $109.2M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $3.6M | $3.0M | $2.6M | $2.9M | $2.9M | $2.8M | $2.9M | $3.6M | $3.5M | $3.7M | $3.4M | $3.5M |
| Total current assets | $87.6M | $98.8M | $106.0M | $134.3M | $150.7M | $141.6M | $132.8M | $144.2M | $170.9M | $185.1M | $176.8M | $186.8M |
| Property, plant & equipment (net) | $29.6M | $30.3M | $31.2M | $28.4M | $29.6M | $30.9M | $32.3M | $33.7M | $35.2M | $36.1M | $36.9M | $38.0M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $45.2M | $47.5M | $52.7M | $37.1M | $31.6M | $54.0M | $76.4M | $80.6M | $65.5M | $66.3M | $90.6M | $92.4M |
| Other non-current assets | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M |
| Total assets | $163.6M | $177.8M | $191.1M | $200.9M | $213.2M | $227.7M | $242.7M | $259.7M | $272.7M | $288.6M | $305.6M | $318.3M |
| Liabilities | ||||||||||||
| Accounts payable | $1.1M | $1.2M | $943,000 | $893,000 | $974,000 | $841,000 | $987,000 | $1.5M | $1.6M | $1.9M | $1.6M | $1.1M |
| Short-term debt | $4.0M | $3.9M | $3.8M | $4.2M | $4.2M | $4.2M | $4.1M | $4.0M | $3.8M | $3.7M | $3.5M | $3.5M |
| Deferred revenue | — | — | — | — | — | — | — | −$1.8M | −$1.7M | −$1.4M | $3.6M | −$468,000 |
| Total current liabilities | $8.6M | $8.3M | $8.0M | $9.0M | $8.1M | $8.2M | $7.6M | $8.7M | $8.7M | $9.2M | $9.1M | $8.9M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $27.8M | $28.9M | $30.0M | $27.0M | $28.2M | $29.3M | $30.5M | $31.6M | $32.6M | $33.6M | $34.6M | $35.6M |
| Other long-term liabilities | $23.8M | $25.0M | $26.2M | $22.8M | $24.0M | $25.1M | $26.4M | $27.6M | $28.8M | $29.9M | $31.1M | $32.2M |
| Total liabilities | $32.5M | $33.4M | $34.1M | $31.8M | $32.1M | $33.3M | $34.0M | $36.3M | $37.5M | $39.2M | $40.2M | $41.1M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $13,000 | $13,000 | $13,000 | $13,000 | $13,000 | $13,000 | $13,000 | $13,000 | $13,000 | $13,000 | $13,000 | $12,000 |
| Retained earnings (deficit) | −$361.2M | −$346.7M | −$332.0M | −$318.2M | −$304.7M | −$289.6M | −$273.0M | −$255.4M | −$239.0M | −$221.0M | −$202.2M | −$185.2M |
| Accumulated other comprehensive income | −$331,000 | −$91,000 | $243,000 | $200,000 | $77,000 | $189,000 | $57,000 | $731,000 | −$546,000 | −$745,000 | −$255,000 | −$2.0M |
| Total shareholders' equity | $131.1M | $144.4M | $157.0M | $169.1M | $181.1M | $194.4M | $208.7M | $223.4M | $235.3M | $249.5M | $265.4M | $277.3M |
| Key figures | ||||||||||||
| Total debt | $27.8M | $28.9M | $30.0M | $27.0M | $28.2M | $29.3M | $30.5M | $31.6M | $32.6M | $33.6M | $34.6M | $35.6M |
| Net cash (debt) | $56.2M | $67.0M | $73.4M | $104.4M | $119.7M | $109.5M | $99.4M | $109.0M | $134.8M | $147.7M | $138.8M | $147.7M |
| Working capital | $79.0M | $90.5M | $98.0M | $125.3M | $142.6M | $133.4M | $125.2M | $135.5M | $162.3M | $175.9M | $167.7M | $177.9M |
| Tangible book value | $131.1M | $144.4M | $157.0M | $169.1M | $181.1M | $194.4M | $208.7M | $223.4M | $235.3M | $249.5M | $265.4M | $277.3M |
| Book value per share | $1.03 | $1.14 | $1.24 | $1.34 | $1.43 | $1.54 | $1.66 | $1.78 | $1.88 | $1.99 | $2.12 | $2.22 |
| Shares outstanding | 126.9M | 126.6M | 126.3M | 126.3M | 126.2M | 126.1M | 125.8M | 125.5M | 125.3M | 125.1M | 125.0M | 124.9M |
| Current ratio | 10.14 | 11.85 | 13.33 | 14.95 | 18.52 | 17.36 | 17.40 | 16.65 | 19.69 | 20.09 | 19.39 | 21.00 |
| Quick ratio | 9.73 | 11.49 | 13.00 | 14.63 | 18.17 | 17.02 | 17.02 | 16.23 | 19.29 | 19.69 | 19.01 | 20.61 |
| Debt / equity | 0.21 | 0.20 | 0.19 | 0.16 | 0.16 | 0.15 | 0.15 | 0.14 | 0.14 | 0.13 | 0.13 | 0.13 |
| Equity / assets | 80.2% | 81.2% | 82.1% | 84.2% | 84.9% | 85.4% | 86.0% | 86.0% | 86.3% | 86.4% | 86.8% | 87.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 26, 2026); data from EODHD.
NAUT financial position
At the end of fiscal 2025 (December 31, 2025), Nautilus Biotechnology had total assets of $191.1 million (down 21.3% from a year earlier), total liabilities of $34.1 million and shareholders' equity of $157.0 million. It held $103.4 million in cash and short-term investments against $30.0 million of debt, a net cash position of $73.4 million. Its current ratio was 13.33. In the latest quarter (ended June 30, 2026) total assets were $163.6 million and equity $131.1 million.
Related: NAUT income statement, NAUT cash flow statement, NAUT key metrics. See the NAUT stock overview for the latest quote and news.
NAUT balance sheet FAQ
What are Nautilus Biotechnology's total assets?
Nautilus Biotechnology reported total assets of $191.1 million at the end of fiscal 2025 (December 31, 2025), compared with $242.7 million a year earlier.
How much debt does Nautilus Biotechnology have?
Nautilus Biotechnology had $30.0 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.19.
How much cash does Nautilus Biotechnology have?
Nautilus Biotechnology held $103.4 million in cash and short-term investments at the end of fiscal 2025; with $30.0 million of debt that is net cash of $73.4 million.
What is Nautilus Biotechnology's book value?
Nautilus Biotechnology's shareholders' equity (book value) was $157.0 million at the end of fiscal 2025, or $1.24 per share.
What is Nautilus Biotechnology's current ratio?
Nautilus Biotechnology had current assets of $106.0 million and current liabilities of $8.0 million, a current ratio of 13.33 (it can cover its short-term obligations).